These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 14348682)
21. [Contribution to the study of extrapyramidal syndromes following use of neuroleptics. Apropos of the use of 2 psychotropic substances with powerful neurotropic activity]. BORENSTEIN P; DABBAH M; BLES G Ann Med Psychol (Paris); 1962 Mar; 120(1)():506-52 concl. PubMed ID: 13871265 [No Abstract] [Full Text] [Related]
23. [Clinical contribution to the knowledge of the extrapyramidal syndrome caused by neuroplegics]. HANAU R Riv Patol Nerv Ment; 1963 Mar; 84():76-88. PubMed ID: 13952468 [No Abstract] [Full Text] [Related]
25. PERPHENAZINE: A REAPPRAISAL AFTER EIGHT YEARS. AYD FJ Dis Nerv Syst; 1964 May; 25():311-8. PubMed ID: 14142793 [No Abstract] [Full Text] [Related]
26. [Side effects exceeding half-time following long-term treatment with psychotropic drugs]. Grahmann H Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 257(1):23-4. PubMed ID: 4231838 [No Abstract] [Full Text] [Related]
27. [Oxygen in the therapy of extrapyramidal syndromes induced by neuroleptics. Practical and theoretical importance]. DEMBER HC; FLORIO D Ann Med Psychol (Paris); 1962 Apr; 120(1)():759-65. PubMed ID: 13885297 [No Abstract] [Full Text] [Related]
32. [CONTRIBUTION TO THE STUDY OF A NEURODYSLEPTIC SYNDROME IN THE COURSE OF HALOPERIDOL THERAPY]. LURIA E; RIZZUTO N Rass Studi Psichiatr; 1964; 53():168-91. PubMed ID: 14178258 [No Abstract] [Full Text] [Related]
33. [CLOPENTHIXOL (CIATYL). NEUROLEPTIC EFFECT WITH SPECIAL REFERENCE TO EXTRAPYRAMIDAL SYMPTOMS]. NOECKER G Med Klin; 1964 May; 59():776-9. PubMed ID: 14225431 [No Abstract] [Full Text] [Related]
34. [Clinical study of ethylbenzatropine (U.K. 738 or tropethydryline), a modifier of extrapyramidal syndromes due to neuroleptics]. BORENSTEIN P; DABBAH M; BLES G; ROUSSEL A; ROSEMBERGER Ann Med Psychol (Paris); 1962 Jul; 120(2)():281-8. PubMed ID: 14013911 [No Abstract] [Full Text] [Related]
35. [Extrapyramidal movement disorders during chlorpromazine and reserpine therapy; clinical and electromyographic studies]. BOURGUIGNON A; DELAY J; DENIKER P; LEMPERIERE T Encephale; 1956; 45(4):1093-8. PubMed ID: 13384344 [No Abstract] [Full Text] [Related]
36. EEG INDUCED FAST ACTIVITY IN CHRONIC MANGANESE POISONING. Naby SDA; Kayed KS; Aref MA Acta Neurol Scand; 1964; 40(3):259-68. PubMed ID: 14192304 [No Abstract] [Full Text] [Related]
37. [RELATION BETWEEN THE THERAPEUTIC EFFECT AND EXTRAPYRAMIDAL SYMPTOMS FOLLOWING THIOPROPERAZINE TREATMENT]. VINAR O; GROF S; VANA J; MATOUSEK M Act Nerv Super (Praha); 1963 May; 5():201-3. PubMed ID: 14070654 [No Abstract] [Full Text] [Related]
38. [ON THE CONTROL OF AKINESIA AND OTHER EXTRAPYRAMIDAL MOTOR DISORDERS WITH L-DOPA (L-DIHYDROXYPHENYLALANINE)]. HIRSCHMANN J; MAYER K Dtsch Med Wochenschr; 1964 Oct; 89():1877-80. PubMed ID: 14211843 [No Abstract] [Full Text] [Related]
39. ELECTROPHYSIOLOGICAL STUDIES IN STEREOTAXIC SURGERY FOR EXTRAPYRAMIDAL DISORDERS. I. SURGICAL LESIONS OF BASAL GANGLIA AND EXCITABILITY OF SPINAL MOTONEURONS. JINNAI D; NISHIMOTO A; NUMOTO M; ADACHI I Confin Neurol; 1963; 23():500-15. PubMed ID: 14063145 [No Abstract] [Full Text] [Related]